Weight loss drug semaglutide could boost heart health of up to 93M patients in US alone Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S
Starting at a lower retatrutide dose and increasing every four weeks gives GI adaptation time to occur as glucagon receptor tone adjusts, reducing nausea, vomiting, and diarrhea during induction
Consult your doctor if pregnant, breastfeeding, or have kidney, pancreas, or thyroid conditions
If you havent received a response within the expected timeframe, call your insurance company to check statussometimes requests get delayed or lost
The key is moderate, consistent fiber intake rather than large boluses